Health Care·Health Care Technology·$2.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.27 | N/A | +0.00% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.27 | N/A | +0.00% |
| Revenue | N/A | N/A | N/A |
Tone: Neutral
Management acknowledged the ongoing challenges but emphasized their commitment to future growth. They did not provide detailed guidance for the next quarter.
Management did not provide specific revenue figures or guidance for the upcoming quarters.
The company remains focused on its long-term growth strategy despite current challenges.
HeartFlow's earnings report showed a loss per share of $0.27, which was in line with expectations, but no revenue figures were disclosed. The stock reacted positively, rising by 4.59%, likely due to investor optimism about the company's long-term strategy despite the lack of specific guidance. The management's focus on growth may have reassured investors amid current uncertainties.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BARRICK MNG CORP
Nov 10, 2025